Evidence map›Paper›PMID 37691215›Full record

ReviewCardiovascular & hematological agents in medicinal chemistry2024

Drug-herb Synergistic Interactions between Clopidogrel and Natural Medicine.

Shitang Ma, Qin Zhang, Jiafu Hou, Shijuan Liu, Chengtao Feng

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cardiovascular & hematological agents in medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Shitang MaCollege of Biological and Pharmaceutical Engineering, West Anhui University, Lu'an, China.
Qin ZhangAnhui Medical College, Hefei, China.
Jiafu HouMudanjiang Medical University, Mudanjiang, China.
Shijuan LiuMudanjiang Medical University, Mudanjiang, China.
Chengtao FengSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
Mudanjiang Medical University · CNAnhui Medical University · CNAnhui University of Traditional Chinese Medicine · CNWest Anhui University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNatural medicine (NM) has been used since ancient times for therapeutic purposes worldwide. Presently, the combination of clopidogrel and NM with a reasonable synergistic effect has gained increasing acceptance in clinical therapeutics.

methodsHere, we have performed a comprehensive retrieval of literature published in both English and Chinese databases until August 1, 2022, studying the synergistic interactions of clopidogrel and NM through pharmacokinetic/pharmacodynamic (PK-PD) analyses. We retrieved 7, 3, and 5 studies on PK analysis and 3, 3, and 8 studies on PD analysis for the interaction of clopidogrel with single herbal medicines, bioactive compounds, and herbal prescriptions, respectively. Most studies on NM have been found to mainly focus on preclinical observations, and there have been fewer clinical PK analyses.

resultsA potential drug-herb interaction has been observed to occur when clopidogrel and NM were metabolized by an enzyme network comprising P-gp, CES1, and CYP450. In contrast, most PD studies have focused on clinical observations, and few preclinical findings have been reported. Some cases have suggested that the combination of the two types of drugs would alter the antiplatelet efficacy and adverse effects. Studies on PK, however, have shown significant or slightly varying results for the drug prototype and its metabolites.

conclusionIn the combination therapies, the interaction between clopidogrel and NM was found to alter antiplatelet aggregation pathways and P2Y12 receptor function.

Indexed as

ClopidogrelDrug SynergismHerb-Drug InteractionsPlatelet Aggregation InhibitorsAnimalsBiological ProductsHumansPlatelet AggregationBiological ProductsClopidogrelPlatelet Aggregation Inhibitorsclinical therapeutics.clopidogrelNatural medicinepharmacodynamicpharmacokineticsynergistic effect

Identifiers

PMID37691215
OpenAlexW4386592525

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.